Lipid raft redox signaling: Molecular mechanisms in health and disease

Antioxidants and Redox Signaling

Volumn 15, Issue 4, 2011, Pages 1043-1083

  Jin, Si ^a   Zhou, Fan ^a   Katirai, Foad ^a   Li, Pin Lan ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKOXY RADICAL; CATALASE; CERAMIDE; CERULENIN; CHOLESTEROL; FILIPIN; HYDROGEN PEROXIDE; HYDROPEROXYL RADICAL; HYDROXYL RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHLOROUS ACID; INOSITOL DERIVATIVE; LEVO ALPHA PHOSPHATIDYL DEXTRO MYOINOSITOL 3,5 BISPHOSPHATE; METHYL BETA CYCLODEXTRIN; MEVINOLIN; OZONE; PEROXY RADICAL; PEROXYNITRITE; PRAVASTATIN; PROTEIN; RADICAL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SIMVASTATIN; SINGLET OXYGEN; SUPEROXIDE; SUPEROXIDE DISMUTASE; THIOREDOXIN; TRANSIENT RECEPTOR PROTEIN C3; TRANSIENT RECEPTOR PROTEIN C4; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANALYTIC METHOD; ATHEROSCLEROSIS; CAVEOLA; CELL FUNCTION; CELL ORGANELLE; CELL VACUOLE; CERAMIDE METABOLISM; CONFOCAL MICROSCOPY; CYTOSKELETON; ENZYME ACTIVITY; ENZYME STRUCTURE; FLUORESCENCE MICROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUORESCENT CONFOCAL MICROSCOPIC IMAGING; HOST RESISTANCE; HUMAN; INFECTION; INTRACELLULAR SIGNALING; KIDNEY DISEASE; LIPID METABOLISM; LIPID RAFT; LYSOSOME; MEMBRANE FRACTION FLOTATION; MOLECULAR DYNAMICS; MOLECULAR MODEL; NEUROLOGIC DISEASE; NONHUMAN; OBESITY; OXIDATION REDUCTION SIGNALING; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PALMITOYLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ASSEMBLY; REGULATORY MECHANISM; REVIEW; TUMOR; VASCULITIS;

CERAMIDES; CHOLESTEROL; DISEASE; HEALTH; HUMANS; MEMBRANE MICRODOMAINS; METABOLIC NETWORKS AND PATHWAYS; NADPH OXIDASE; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 79960427714     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3619     Document Type: Review

References (454)

1. Abdel Shakor AB, Kwiatkowska K, and Sobota A. Cell surface ceramide generation precedes and controls FcgammaRII clustering and phosphorylation in rafts. J Biol Chem 279: 36778-36787, 2004. (Pubitemid 39129026)
2. Abrahamsen H, Baillie G, Ngai J, Vang T, Nika K, Ruppelt A, Mustelin T, Zaccolo M, Houslay M, and Tasken K. TCRand CD28-mediated recruitment of phosphodiesterase 4 to lipid rafts potentiates TCR signaling. J Immunol 173: 4847-4858, 2004. (Pubitemid 39387765)
3. Adam D, Heinrich M, Kabelitz D, and Schutze S. Ceramide: does it matter for T cells? Trends Immunol 23: 1-4, 2002. (Pubitemid 34098949)
4. Adam RM, Yang W, Di Vizio D, Mukhopadhyay NK, and Steen H. Rapid preparation of nuclei-depleted detergentresistant membrane fractions suitable for proteomics analysis. BMC Cell Biol 9: 30, 2008.
5. Ago T, Kitazono T, Kuroda J, Kumai Y, Kamouchi M, Ooboshi H, Wakisaka M, Kawahara T, Rokutan K, Ibayashi S, and Iida M. NAD(P)H oxidases in rat basilar arterial endothelial cells. Stroke 36: 1040-1046, 2005. (Pubitemid 40629300)
6. Aisenbrey C, Borowik T, Bystrom R, Bokvist M, Lindstrom F, Misiak H, Sani MA, and Grobner G. How is protein aggregation in amyloidogenic diseases modulated by biological membranes? Eur Biophys J 37: 247-255, 2008.
7. Alicia S, Angelica Z, Carlos S, Alfonso S, and Vaca L. STIM1 converts TRPC1 from a receptor-operated to a storeoperated channel: moving TRPC1 in and out of lipid rafts. Cell Calcium 44: 479-491, 2008.
8. Allen JA, Halverson-Tamboli RA, and Rasenick MM. Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci 8: 128-140, 2007. (Pubitemid 46146951)
9. Alonso MA and Millan J. The role of lipid rafts in signalling and membrane trafficking in T lymphocytes. J Cell Sci 114: 3957-3965, 2001. (Pubitemid 33115017)
10. Aman MJ and Ravichandran KS. A requirement for lipid rafts in B cell receptor induced Ca(2 + ) flux. Curr Biol 10: 393-396, 2000. (Pubitemid 30213385)
11. Ameziane-El-Hassani R, Morand S, Boucher JL, Frapart YM, Apostolou D, Agnandji D, Gnidehou S, Ohayon R, Noel-Hudson MS, Francon J, Lalaoui K, Virion A, and Dupuy C. Dual oxidase-2 has an intrinsic Ca2 +-dependent H2O2-generating activity. J Biol Chem 280: 30046-30054, 2005. (Pubitemid 41216180)
12. Ammons MC, Siemsen DW, Nelson-Overton LK, Quinn MT, and Gauss KA. Binding of pleomorphic adenoma gene-like 2 to the tumor necrosis factor (TNF)-alpharesponsive region of the NCF2 promoter regulates p67(phox) expression and NADPH oxidase activity. J Biol Chem 282: 17941-17952, 2007. (Pubitemid 47100276)
13. Anderson RG and Jacobson K. A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains. Science 296: 1821-1825, 2002. (Pubitemid 34596260)
14. Axelrod D. Total internal reflection fluorescence microscopy in cell biology. Traffic 2: 764-774, 2001. (Pubitemid 33040255)
15. Ayuyan AG and Cohen FS. Lipid peroxides promote large rafts: effects of excitation of probes in fluorescence microscopy and electrochemical reactions during vesicle formation. Biophys J 91: 2172-2183, 2006. (Pubitemid 44352400)
16. Azad MB, Chen Y, and Gibson SB. Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxid Redox Signal 11: 777-790, 2009.
17. Azad N, Rojanasakul Y, and Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. J Toxicol Environ Health B Crit Rev 11: 1-15, 2008.
18. Babior BM, Lambeth JD, and Nauseef W. The neutrophil NADPH oxidase. Arch Biochem Biophys 397: 342-344, 2002. (Pubitemid 34852301)
19. Bacia K and Schwille P. A dynamic view of cellular processes by in vivo fluorescence auto-and cross-correlation spectroscopy. Methods 29: 74-85, 2003. (Pubitemid 36259914)
20. Bagi Z, Feher A, and Beleznai T. Preserved coronary arteriolar dilatation in patients with type 2 diabetes mellitus: implications for reactive oxygen species. Pharmacol Rep 61: 99-104, 2009.
21. Bagnat M, Keranen S, Shevchenko A, and Simons K. Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc Natl Acad Sci USA 97: 3254-3259, 2000. (Pubitemid 30183288)
22. Bain AJ, Marsh RJ, Armoogum DA, Mongin O, Porres L, and Blanchard-Desce M. Time-resolved stimulated emission depletion in two-photon excited states. Biochem Soc Trans 31: 1047-1051, 2003. (Pubitemid 37305043)
23. Bainton DF. The discovery of lysosomes. J Cell Biol 91: 66s-76s, 1981. (Pubitemid 12177861)
24. Banfi B, Malgrange B, Knisz J, Steger K, Dubois-Dauphin M, and Krause KH. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem 279: 46065-46072, 2004. (Pubitemid 39491600)
25. Banfi B, Tirone F, Durussel I, Knisz J, Moskwa P, Molnar GZ, Krause KH, and Cox JA. Mechanism of Ca2 + activation of the NADPH oxidase 5 (NOX5). J Biol Chem 279: 18583-18591, 2004. (Pubitemid 38623279)
26. Bao JX, Jin S, Zhang F, Wang ZC, Li N, and Li PL. Activation of membrane NADPH oxidase associated with lysosome-targeted acid sphingomyelinase in coronary endothelial cells. Antioxid Redox Signal 12: 703-712, 2010.
27. Bao JX, Xia M, Poklis JL, Han WQ, Brimson C, and Li PL. Triggering role of acid sphingomyelinase in endothelial lysosome-membrane fusion and dysfunction in coronary arteries. Am J Physiol Heart Circ Physiol 298: H992-H1002, 2010.
28. Baran CP, Zeigler MM, Tridandapani S, and Marsh CB. The role of ROS and RNS in regulating life and death of blood monocytes. Curr Pharm Des 10: 855-866, 2004. (Pubitemid 38380064)
29. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, Qian T, Schoonhoven R, Hagedorn CH, Lemasters JJ, and Brenner DA. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112: 1383-1394, 2003. (Pubitemid 38057692)
30. Becker KA, Gellhaus A, Winterhager E, and Gulbins E. Ceramide-enriched membrane domains in infectious biology and development. Subcell Biochem 49: 523-538, 2008.
31. Bedard K and Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313, 2007. (Pubitemid 46209993)
32. Bell EL and Chandel NS. Mitochondrial oxygen sensing: regulation of hypoxia-inducible factor by mitochondrial generated reactive oxygen species. Essays Biochem 43: 17-27, 2007.
33. Bionda C, Hadchity E, Alphonse G, Chapet O, Rousson R, Rodriguez-Lafrasse C, and Ardail D. Radioresistance of human carcinoma cells is correlated to a defect in raft membrane clustering. Free Radic Biol Med 43: 681-694, 2007. (Pubitemid 47102119)
34. Bismuth J, Lin P, Yao Q, and Chen C. Ceramide: a common pathway for atherosclerosis? Atherosclerosis 196: 497-504, 2008.
35. Blank U, Cyprien B, Martin-Verdeaux S, Paumet F, Pombo I, Rivera J, Roa M, and Varin-Blank N. SNAREs and associated regulators in the control of exocytosis in the RBL-2H3 mast cell line. Mol Immunol 38: 1341-1345, 2002. (Pubitemid 35253774)
36. Block K, Gorin Y, and Abboud HE. Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci USA 106: 14385-14390, 2009.
37. Bocker M, Muschter S, Schmitt EK, Steinem C, and Schaffer TE. Imaging and patterning of pore-suspending membranes with scanning ion conductance microscopy. Langmuir 25: 3022-3028, 2009.
38. Boini KM, Zhang C, Xia M, Poklis JL, and Li PL. Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet. J Pharmacol Exp Ther 334: 839-846, 2010.
39. Bollinger CR, Teichgraber V, and Gulbins E. Ceramideenriched membrane domains. Biochim Biophys Acta 1746: 284-294, 2005.
40. Boniface JJ, Rabinowitz JD, Wulfing C, Hampl J, Reich Z, Altman JD, Kantor RM, Beeson C, McConnell HM, and Davis MM. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. Immunity 9: 459-466, 1998. (Pubitemid 28499197)
41. Borregaard N, Heiple JM, Simons ER, and Clark RA. Subcellular localization of the b-cytochrome component of the human neutrophil microbicidal oxidase: translocation during activation. J Cell Biol 97: 52-61, 1983. (Pubitemid 13076517)
42. Bowers WE. Christian de Duve and the discovery of lysosomes and peroxisomes. Trends Cell Biol 8: 330-333, 1998. (Pubitemid 28362591)
43. Brandes RP, Fleming I, and Busse R. Endothelial aging. Cardiovasc Res 66: 286-294, 2005. (Pubitemid 40471043)
44. Brandes RP and Kreuzer J. Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 65: 16-27, 2005. (Pubitemid 40038475)
45. Brown DA and London E. Functions of lipid rafts in biological membranes. Annu Rev Cell Dev Biol 14: 111-136, 1998. (Pubitemid 29001451)
46. Brown DA and London E. Structure and function of sphingolipid-and cholesterol-rich membrane rafts. J Biol Chem 275: 17221-17224, 2000. (Pubitemid 30430750)
47. Brown DA and Rose JK. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68: 533-544, 1992.
48. Brown DI and Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 47: 1239-1253, 2009.
49. Bryant MR, Marta CB, Kim FS, and Bansal R. Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes. Glia 57: 935-946, 2009.
50. Burdon RH. Control of cell proliferation by reactive oxygen species. Biochem Soc Trans 24: 1028-1032, 1996.
51. Cai H. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res 96: 818-822, 2005. (Pubitemid 40604964)
52. Cai H. A new mechanism for flow-mediated vasoprotection? Focus on "lung endothelial cell proliferation with decreased shear stress is mediated by reactive oxygen species." Am J Physiol Cell Physiol 290: C35-C36, 2006.
53. Canevari L and Clark JB. Alzheimer's disease and cholesterol: the fat connection. Neurochem Res 32: 739-750, 2007. (Pubitemid 46481303)
54. Caroni P. New EMBO members' review: actin cytoskeleton regulation through modulation of PI(4,5)P(2) rafts. EMBO J 20: 4332-4336, 2001. (Pubitemid 32772026)
55. Casadesus G, Smith MA, Zhu X, Aliev G, Cash AD, Honda K, Petersen RB, and Perry G. Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. J Alzheimers Dis 6: 165-169, 2004. (Pubitemid 38560252)
56. Chatterjee M and Wu S. Cell line dependent involvement of ceramide in ultraviolet light-induced apoptosis. Mol Cell Biochem 219: 21-27, 2001. (Pubitemid 32331440)
57. Cheng G, Cao Z, Xu X, van Meir EG, and Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140, 2001. (Pubitemid 32488913)
58. Cheng H, Vetrivel KS, Gong P, Meckler X, Parent A, and Thinakaran G. Mechanisms of disease: new therapeutic strategies for Alzheimer's disease-targeting APP processing in lipid rafts. Nat Clin Pract Neurol 3: 374-382, 2007. (Pubitemid 47040327)
59. Cheng PC, Dykstra ML, Mitchell RN, and Pierce SK. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J Exp Med 190: 1549-1560, 1999. (Pubitemid 30002337)
60. Cheng ZJ, Singh RD, Marks DL, and Pagano RE. Membrane microdomains, caveolae, and caveolar endocytosis of sphingolipids. Mol Membr Biol 23: 101-110, 2006.
61. Chini B and Parenti M. G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats. J Mol Endocrinol 42: 371-379, 2009.
62. Chini EN, Beers KW, and Dousa TP. Nicotinate adenine dinucleotide phosphate (NAADP) triggers a specific calcium release system in sea urchin eggs. J Biol Chem 270: 3216-3223, 1995.
63. Ciarlo L, Manganelli V, Garofalo T, Matarrese P, Tinari A, Misasi R, Malorni W, and Sorice M. Association of fission proteins with mitochondrial raft-like domains. Cell Death Differ 17: 1047-1058, 2010.
64. Clempus RE and Griendling KK. Reactive oxygen species signaling in vascular smooth muscle cells. Cardiovasc Res 71: 216-225, 2006.
65. Colavitti R and Finkel T. Reactive oxygen species as mediators of cellular senescence. IUBMB Life 57: 277-281, 2005. (Pubitemid 40904255)
66. Connor KM, Subbaram S, Regan KJ, Nelson KK, Mazurkiewicz JE, Bartholomew PJ, Aplin AE, Tai YT, Aguirre-Ghiso J, Flores SC, and Melendez JA. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. J Biol Chem 280: 16916-16924, 2005. (Pubitemid 41389151)
67. Cordy JM, Hooper NM, and Turner AJ. The involvement of lipid rafts in Alzheimer's disease. Mol Membr Biol 23: 111-122, 2006.
68. Cremesti AE, Goni FM, and Kolesnick R. Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? FEBS Lett 531: 47-53, 2002. (Pubitemid 35232783)
69. Cutler RG and Mattson MP. Sphingomyelin and ceramide as regulators of development and lifespan. Mech Ageing Dev 122: 895-908, 2001. (Pubitemid 32441613)
70. Dang PM, Cross AR, Quinn MT, and Babior BM. Assembly of the neutrophil respiratory burst oxidase: a direct interaction between p67PHOX and cytochrome b558 II. Proc Natl Acad Sci USA 99: 4262-4265, 2002. (Pubitemid 34285974)
71. de Haas M, Vossebeld PJ, von dem Borne AE, and Roos D. Fc gamma receptors of phagocytes. J Lab Clin Med 126: 330-341, 1995.
72. Del Prete A, Zaccagnino P, Di Paola M, Saltarella M, Oliveros Celis C, Nico B, Santoro G, and Lorusso M. Role of mitochondria and reactive oxygen species in dendritic cell differentiation and functions. Free Radic Biol Med 44: 1443-1451, 2008.
73. Delles C, Miller WH, and Dominiczak AF. Targeting reactive oxygen species in hypertension. Antioxid Redox Signal 10: 1061-1077, 2008. (Pubitemid 351451714)
74. Desplanques AS, Nauwynck HJ, Tilleman K, Deforce D, and Favoreel HW. Tyrosine phosphorylation and lipid raft association of pseudorabies virus glycoprotein E during antibody-mediated capping. Virology 362: 60-66, 2007. (Pubitemid 46617692)
75. Di Vizio D, Solomon KR, and Freeman MR. Cholesterol and cholesterol-rich membranes in prostate cancer: an update. Tumori 94: 633-639, 2008.
76. Dikalova AE, Gongora MC, Harrison DG, Lambeth JD, Dikalov S, and Griendling KK. Upregulation of Nox1 in vascular smooth muscle leads to impaired endotheliumdependent relaxation via enos uncoupling. Am J Physiol Heart Circ Physiol 299: H673-H679, 2010.
77. Donati RJ and Rasenick MM. Chronic antidepressant treatment prevents accumulation of gsalpha in cholesterolrich, cytoskeletal-associated, plasma membrane domains (lipid rafts). Neuropsychopharmacology 30: 1238-1245, 2005. (Pubitemid 40848078)
78. Downey GP, Fukushima T, and Fialkow L. Signaling mechanisms in human neutrophils. Curr Opin Hematol 2: 76-88, 1995.
79. Draper JM, Xia Z, and Smith CD. Cellular palmitoylation and trafficking of lipidated peptides. J Lipid Res 48: 1873-1884, 2007. (Pubitemid 47312002)
80. Dremina ES, Sharov VS, and Schoneich C. Protein tyrosine nitration in rat brain is associated with raft proteins, flotillin-1 and alpha-tubulin: effect of biological aging. J Neurochem 93: 1262-1271, 2005. (Pubitemid 40776579)
81. Dumitru CA, Zhang Y, Li X, and Gulbins E. Ceramide: a novel player in reactive oxygen species-induced signaling? Antioxid Redox Signal 9: 1535-1540, 2007. (Pubitemid 47255029)
82. Dworakowski R, Anilkumar N, Zhang M, and Shah AM. Redox signalling involving NADPH oxidase-derived reactive oxygen species. Biochem Soc Trans 34: 960-964, 2006. (Pubitemid 44796460)
83. Eggeling C, Ringemann C, Medda R, Schwarzmann G, Sandhoff K, Polyakova S, Belov VN, Hein B, von Middendorff C, Schonle A, and Hell SW. Direct observation of the nanoscale dynamics of membrane lipids in a living cell. Nature 457: 1159-1162, 2009.
84. Eid AA, Gorin Y, Fagg BM, Maalouf R, Barnes JL, Block K, and Abboud HE. Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases. Diabetes 58: 1201-1211, 2009.
85. El-Benna J, Dang PM, and Gougerot-Pocidalo MA. Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin Immunopathol 30: 279-289, 2008.
86. El Kirat K, Morandat S, and Dufrene YF. Nanoscale analysis of supported lipid bilayers using atomic force microscopy. Biochim Biophys Acta 1798: 750-765, 2010.
87. Esen M, Schreiner B, Jendrossek V, Lang F, Fassbender K, Grassme H, and Gulbins E. Mechanisms of Staphylococcus aureus induced apoptosis of human endothelial cells. Apoptosis 6: 431-439, 2001. (Pubitemid 33078753)
88. Eum SY, Andras I, Hennig B, and Toborek M. NADPH oxidase and lipid raft-associated redox signaling are required for PCB153-induced upregulation of cell adhesion molecules in human brain endothelial cells. Toxicol Appl Pharmacol 240: 299-305, 2009.
89. Fallahi-Sichani M and Linderman JJ. Lipid raft-mediated regulation of G-protein coupled receptor signaling by ligands which influence receptor dimerization: a computational study. PLoS One 4: e6604, 2009.
90. Feuk-Lagerstedt E, Movitz C, Pellme S, Dahlgren C, and Karlsson A. Lipid raft proteome of the human neutrophil azurophil granule. Proteomics 7: 194-205, 2007. (Pubitemid 46184083)
91. Finkel T and Holbrook NJ. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247, 2000.
92. Fischer H. Mechanisms and function of DUOX in epithelia of the lung. Antioxid Redox Signal 11: 2453-2465, 2009.
93. Fish KN. Total internal reflection fluorescence (TIRF) microscopy. Curr Protoc Cytom Chapter 12: Unit12.18, 2009.
94. Flowers F and Zimmerman JJ. Reactive oxygen species in the cellular pathophysiology of shock. New Horiz 6: 169-180, 1998. (Pubitemid 28283765)
95. Folkman J. Antiangiogenesis in cancer therapy-endostatin and its mechanisms of action. Exp Cell Res 312: 594-607, 2006. (Pubitemid 43290336)
96. Forman HJ and Torres M. Redox signaling in macrophages. Mol Aspects Med 22: 189-216, 2001. (Pubitemid 33000522)
97. Foster JD, Adkins SD, Lever JR, and Vaughan RA. Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. J Neurochem 105: 1683-1699, 2008. (Pubitemid 351678491)
98. Foster LJ, De Hoog CL, and Mann M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci USA 100: 5813-5818, 2003. (Pubitemid 36576890)
99. Frank PG, Woodman SE, Park DS, and Lisanti MP. Caveolin, caveolae, and endothelial cell function. Arterioscler Thromb Vasc Biol 23: 1161-1168, 2003. (Pubitemid 36871269)
100. Frey RS, Rahman A, Kefer JC, Minshall RD, and Malik AB. PKCzeta regulates TNF-alpha-induced activation of NADPH oxidase in endothelial cells. Circ Res 90: 1012-1019, 2002. (Pubitemid 34633868)
101. Friedrichson T and Kurzchalia TV. Microdomains of GPIanchored proteins in living cells revealed by crosslinking. Nature 394: 802-805, 1998. (Pubitemid 28391647)
102. Fubini B and Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med 34: 1507-1516, 2003. (Pubitemid 36638711)
103. Fuhler GM, Blom NR, Coffer PJ, Drayer AL, and Vellenga E. The reduced GM-CSF priming of ROS production in granulocytes from patients with myelodysplasia is associated with an impaired lipid raft formation. J Leukoc Biol 81: 449-457, 2007. (Pubitemid 46198396)
104. Fujimoto S, Satoh M, Horike H, Hatta H, Haruna Y, Kobayashi S, Namikoshi T, Arakawa S, Tomita N, and Kashihara N. Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production. Hypertens Res 31: 305-313, 2008. (Pubitemid 351461111)
105. Fujimura Y, Tachibana H, and Yamada K. Lipid raftassociated catechin suppresses the FcepsilonRI expression by inhibiting phosphorylation of the extracellular signalregulated kinase1/2. FEBS Lett 556: 204-210, 2004. (Pubitemid 38058580)
106. Fukai T, Folz RJ, Landmesser U, and Harrison DG. Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc Res 55: 239-249, 2002. (Pubitemid 34775274)
107. Fulton DJ. Nox5 and the regulation of cellular function. Antioxid Redox Signal 11: 2443-2452, 2009.
108. Galan C, Woodard GE, Dionisio N, Salido GM, and Rosado JA. Lipid rafts modulate the activation but not the maintenance of store-operated Ca(2 + ) entry. Biochim Biophys Acta 1803: 1083-1093, 2010.
109. Galli F. Membrane rafts and redox therapies in cancer: a commentary on Radioresistance of human carcinoma cells is correlated to a defect in raft membrane clustering. Free Radic Biol Med 43: 678-680, 2007. (Pubitemid 47102133)
110. Gamalei IA, Efremova TN, Kirpichnikova KM, Komissarchik YY, Kever LV, Polozov YV, and Khaitlina SY. Decreased sensitivity of transformed 3T3-SV40 cells treated with N-acetylcysteine to bacterial invasion. Bull Exp Biol Med 142: 90-93, 2006. (Pubitemid 44644606)
111. Gambara G, Billington RA, Debidda M, D'Alessio A, Palombi F, Ziparo E, Genazzani AA, and Filippini A. NAADP-induced Ca(2 + signaling in response to endothelin is via the receptor subtype B and requires the integrity of lipid rafts/caveolae. J Cell Physiol 216: 396-404, 2008. (Pubitemid 351898466)
112. Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, and Sessa WC. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci USA 93: 6448-6453, 1996. (Pubitemid 26230326)
113. Garcia RC and Segal AW. Changes in the subcellular distribution of the cytochrome b-245 on stimulation of human neutrophils. Biochem J 219: 233-242, 1984. (Pubitemid 14171467)
114. Gauss KA, Nelson-Overton LK, Siemsen DW, Gao Y, De-Leo FR, and Quinn MT. Role of NF-kappaB in transcriptional regulation of the phagocyte NADPH oxidase by tumor necrosis factor-alpha. J Leukoc Biol 82: 729-741, 2007. (Pubitemid 47367165)
115. Geiszt M, Kopp JB, Varnai P, and Leto TL. Identification of renox, an NAD(P)H oxidase in kidney. Proc Natl Acad Sci USA 97: 8010-8014, 2000. (Pubitemid 30460764)
116. Gendzwill A. [Reactive oxygen species and vascular hyporeactivity in septic shock. Part I-reactive oxygen species and vascular hyporeactivity]. Pol Merkur Lekarski 23: 280-283, 2007.
117. Gendzwill A. [Reactive oxygen species and vascular hyporeactivity in septic shock. Part II-scavengers and vascular hyporeactivity in septic shock]. Pol Merkur Lekarski 23: 284-287, 2007.
118. Gerst JE. SNAREs and SNARE regulators in membrane fusion and exocytosis. Cell Mol Life Sci 55: 707-734, 1999. (Pubitemid 29257623)
119. Goligorsky MS, Li H, Brodsky S, and Chen J. Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. Am J Physiol Renal Physiol 283: F1-F10, 2002. (Pubitemid 34680466)
120. Gong XM, Franzin CM, Thai K, Yu J, and Marassi FM. Nuclear magnetic resonance structural studies of membrane proteins in micelles and bilayers. Methods Mol Biol 400: 515-529, 2007. (Pubitemid 350183712)
121. Gongora MC, Lob HE, Landmesser U, Guzik TJ, Martin WD, Ozumi K, Wall SM, Wilson DS, Murthy N, Gravanis M, Fukai T, and Harrison DG. Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome. Am J Pathol 173: 915-926, 2008.
122. Goni FM and Alonso A. Sphingomyelinases: enzymology and membrane activity. FEBS Lett 531: 38-46, 2002. (Pubitemid 35232782)
123. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, and Abboud HE. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem 280: 39616-39626, 2005. (Pubitemid 41713921)
124. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, and Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 87: 26-32, 2000. (Pubitemid 30456931)
125. Goswami D, Gowrishankar K, Bilgrami S, Ghosh S, Raghupathy R, Chadda R, Vishwakarma R, Rao M, and Mayor S. Nanoclusters of GPI-anchored proteins are formed by cortical actin-driven activity. Cell 135: 1085-1097, 2008.
126. Goswami SK, Maulik N, and Das DK. Ischemia-reperfusion and cardioprotection: a delicate balance between reactive oxygen species generation and redox homeostasis. Ann Med 39: 275-289, 2007. (Pubitemid 46897661)
127. Grammatikos G, Teichgraber V, Carpinteiro A, Trarbach T, Weller M, Hengge UR, and Gulbins E. Overexpression of acid sphingomyelinase sensitizes glioma cells to chemotherapy. Antioxid Redox Signal 9: 1449-1456, 2007. (Pubitemid 47255025)
128. Grandvaux N, Soucy-Faulkner A, and Fink K. Innate host defense: Nox and Duox on phox's tail. Biochimie 89: 1113-1122, 2007. (Pubitemid 47260647)
129. Grassme H, Becker KA, Zhang Y, and Gulbins E. Ceramide in bacterial infections and cystic fibrosis. Biol Chem 389: 1371-1379, 2008.
130. Grassme H, Gulbins E, Brenner B, Ferlinz K, Sandhoff K, Harzer K, Lang F, and Meyer TF. Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell 91: 605-615, 1997. (Pubitemid 27513652)
131. Grassme H, Jekle A, Riehle A, Schwarz H, Berger J, Sandhoff K, Kolesnick R, and Gulbins E. CD95 signaling via ceramide-rich membrane rafts. J Biol Chem 276: 20589-20596, 2001.
132. Grassme H, Jendrossek V, Bock J, Riehle A, and Gulbins E. Ceramide-rich membrane rafts mediate CD40 clustering. J Immunol 168: 298-307, 2002. (Pubitemid 34014130)
133. Grassme H, Jendrossek V, Riehle A, von Kurthy G, Berger J, Schwarz H, Weller M, Kolesnick R, and Gulbins E. Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts. Nat Med 9: 322-330, 2003. (Pubitemid 36362788)
134. Grassme H, Riehle A, Wilker B, and Gulbins E. Rhinoviruses infect human epithelial cells via ceramide-enriched membrane platforms. J Biol Chem 280: 26256-26262, 2005. (Pubitemid 41022223)
135. Greaves J and Chamberlain LH. Palmitoylation-dependent protein sorting. J Cell Biol 176: 249-254, 2007. (Pubitemid 46184875)
136. Griendling KK. Novel NAD(P)H oxidases in the cardiovascular system. Heart 90: 491-493, 2004. (Pubitemid 38530160)
137. Griendling KK, Minieri CA, Ollerenshaw JD, and Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148, 1994. (Pubitemid 24176909)
138. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000. (Pubitemid 30165039)
139. Griffiths G. Cell evolution and the problem of membrane topology. Nat Rev Mol Cell Biol 8: 1018-1024, 2007. (Pubitemid 350174638)
140. Groemping Y, Lapouge K, Smerdon SJ, and Rittinger K. Molecular basis of phosphorylation-induced activation of the NADPH oxidase. Cell 113: 343-355, 2003. (Pubitemid 36556116)
141. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschlager N, Endres S, Hartmann G, Tardivel A, Schweighoffer E, Tybulewicz V, Mocsai A, Tschopp J, and Ruland J. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 459: 433-436, 2009.
142. Guichard C, Pedruzzi E, Fay M, Ben Mkaddem S, Coant N, Daniel F, and Ogier-Denis E. [The Nox/Duox family of ROS-generating NADPH oxidases]. Med Sci (Paris) 22: 953-959, 2006. (Pubitemid 44845306)
143. Gulbins E. Highlight: sphingolipids-signals and disease. Biol Chem 389: 1347-1348, 2008.
144. Gulbins E and Grassme H. Ceramide and cell death receptor clustering. Biochim Biophys Acta 1585: 139-145, 2002. (Pubitemid 36092078)
145. Gulbins E and Kolesnick R. Raft ceramide in molecular medicine. Oncogene 22: 7070-7077, 2003. (Pubitemid 37386676)
146. Gulbins E and Li PL. Physiological and pathophysiological aspects of ceramide. Am J Physiol Regul Integr Comp Physiol 290: R11-R26, 2006.
147. Gupte SA and Wolin MS. Oxidant and redox signaling in vascular oxygen sensing: implications for systemic and pulmonary hypertension. Antioxid Redox Signal 10: 1137-1152, 2008. (Pubitemid 351451711)
148. Guzy RD and Schumacker PT. Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia. Exp Physiol 91: 807-819, 2006. (Pubitemid 44266577)
149. Halliwell B and Cross CE. Oxygen-derived species: their relation to human disease and environmental stress. Environ Health Perspect 102 Suppl 10: 5-12, 1994.
150. Han W, Li H, Villar VA, Pascua AM, Dajani MI, Wang X, Natarajan A, Quinn MT, Felder RA, Jose PA, and Yu P. Lipid rafts keep NADPH oxidase in the inactive state in human renal proximal tubule cells. Hypertension 51: 481-487, 2008. (Pubitemid 351156436)
151. Hancock JF. Lipid rafts: contentious only from simplistic standpoints. Nat Rev Mol Cell Biol 7: 456-462, 2006. (Pubitemid 44050099)
152. Hannun YA and Bell RM. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science 243: 500-507, 1989. (Pubitemid 19048748)
153. Hansberg W, de Groot H, and Sies H. Reactive oxygen species associated with cell differentiation in Neurospora crassa. Free Radic Biol Med 14: 287-293, 1993. (Pubitemid 23066369)
154. Hansen CG and Nichols BJ. Exploring the caves: cavins, caveolins and caveolae. Trends Cell Biol 20: 177-186, 2010.
155. Hansen GH, Niels-Christiansen LL, Thorsen E, Immerdal L, and Danielsen EM. Cholesterol depletion of enterocytes. Effect on the Golgi complex and apical membrane trafficking. J Biol Chem 275: 5136-5142, 2000. (Pubitemid 30108916)
156. Hara T, Kondo N, Nakamura H, Okuyama H, Mitsui A, Hoshino Y, and Yodoi J. Cell-surface thioredoxin-1: possible involvement in thiol-mediated leukocyte-endothelial cell interaction through lipid rafts. Antioxid Redox Signal 9: 1427-1437, 2007. (Pubitemid 47255023)
157. Harder T and Simons K. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr Opin Cell Biol 9: 534-542, 1997. (Pubitemid 27354763)
158. Hauck CR, Grassme H, Bock J, Jendrossek V, Ferlinz K, Meyer TF, and Gulbins E. Acid sphingomyelinase is involved in CEACAM receptor-mediated phagocytosis of Neisseria gonorrhoeae. FEBS Lett 478: 260-266, 2000. (Pubitemid 30621628)
159. Head BP, Patel HH, Roth DM, Murray F, Swaney JS, Niesman IR, Farquhar MG, and Insel PA. Microtubules and actin microfilaments regulate lipid raft/caveolae localization of adenylyl cyclase signaling components. J Biol Chem 281: 26391-26399, 2006. (Pubitemid 44401847)
160. Helms JB and Zurzolo C. Lipids as targeting signals: lipid rafts and intracellular trafficking. Traffic 5: 247-254, 2004. (Pubitemid 38455748)
161. Hess ST, Gould TJ, Gudheti MV, Maas SA, Mills KD, and Zimmerberg J. Dynamic clustered distribution of hemagglutinin resolved at 40nm in living cell membranes discriminates between raft theories. Proc Natl Acad Sci USA 104: 17370-17375, 2007. (Pubitemid 350219826)
162. Hildeman DA. Regulation of T-cell apoptosis by reactive oxygen species. Free Radic Biol Med 36: 1496-1504, 2004. (Pubitemid 38746558)
163. Hilenski LL, Clempus RE, Quinn MT, Lambeth JD, and Griendling KK. Distinct subcellular localizations of Nox1 and Nox4 in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 677-683, 2004. (Pubitemid 38451603)
164. Hill JM, Steiner I, Matthews KE, Trahan SG, Foster TP, and Ball MJ. Statins lower the risk of developing Alzheimer's disease by limiting lipid raft endocytosis and decreasing the neuronal spread of Herpes simplex virus type 1. Med Hypotheses 64: 53-58, 2005. (Pubitemid 39469235)
165. Hillyard DZ, Jardine AG, McDonald KJ, and Cameron AJ. Fluvastatin inhibits raft dependent Fcgamma receptor signalling in human monocytes. Atherosclerosis 172: 219-228, 2004. (Pubitemid 38167532)
166. Hillyard DZ, Nutt CD, Thomson J, McDonald KJ, Wan RK, Cameron AJ, Mark PB, and Jardine AG. Statins inhibit NK cell cytotoxicity by membrane raft depletion rather than inhibition of isoprenylation. Atherosclerosis 191: 319-325, 2007. (Pubitemid 46400716)
167. Hirooka Y. Role of reactive oxygen species in brainstem in neural mechanisms of hypertension. Auton Neurosci 142: 20-24, 2008.
168. Hoekstra D, Maier O, van der Wouden JM, Slimane TA, and van ISC. Membrane dynamics and cell polarity: the role of sphingolipids. J Lipid Res 44: 869-77, 2003. (Pubitemid 37279646)
169. Holowka D, Sheets ED, and Baird B. Interactions between Fc(epsilon)RI and lipid raft components are regulated by the actin cytoskeleton. J Cell Sci 113 (Pt 6): 1009-1019, 2000. (Pubitemid 30179480)
170. Holz RW and Axelrod D. Secretory granule behaviour adjacent to the plasma membrane before and during exocytosis: total internal reflection fluorescence microscopy studies. Acta Physiol (Oxf) 192: 303-307, 2008. (Pubitemid 351161002)
171. Hu J, Jia S, and Li P. Statins Block the Formation of Lipid Raft Redox Signaling Platforms in Coronary Endothelial Cells. FASEB J 23, 2009.
172. Hung YH, Robb EL, Volitakis I, Ho M, Evin G, Li QX, Culvenor JG, Masters CL, Cherny RA, and Bush AI. Paradoxical condensation of copper with elevated beta-amyloid in lipid rafts under cellular copper deficiency conditions: implications for Alzheimer disease. J Biol Chem 284: 21899-21907, 2009.
173. Huynh C, Roth D, Ward DM, Kaplan J, and Andrews NW. Defective lysosomal exocytosis and plasma membrane repair in Chediak-Higashi/beige cells. Proc Natl Acad Sci USA 101: 16795-16800, 2004. (Pubitemid 39601318)
174. Hwang J, Kleinhenz DJ, Lassegue B, Griendling KK, Dikalov S, and Hart CM. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. Am J Physiol Cell Physiol 288: C899-C905, 2005. (Pubitemid 40395068)
175. Hwang LC and Wohland T. Recent advances in fluorescence cross-correlation spectroscopy. Cell Biochem Biophys 49: 1-13, 2007. (Pubitemid 47415342)
176. Iadecola C and Gorelick PB. Hypertension, angiotensin, and stroke: beyond blood pressure. Stroke 35: 348-350, 2004. (Pubitemid 38174402)
177. Ikonen E and Vainio S. Lipid microdomains and insulin resistance: is there a connection? Sci STKE 2005: pe3, 2005.
178. Inokuchi J. Insulin resistance as a membrane microdomain disorder. Biol Pharm Bull 29: 1532-1537, 2006. (Pubitemid 44166346)
179. Insel PA, Head BP, Ostrom RS, Patel HH, Swaney JS, Tang CM, and Roth DM. Caveolae and lipid rafts: G proteincoupled receptor signaling microdomains in cardiac myocytes. Ann N Y Acad Sci 1047: 166-172, 2005. (Pubitemid 41123837)
180. Israelachvili JN. Refinement of the fluid-mosaic model of membrane structure. Biochim Biophys Acta 469: 221-225, 1977. (Pubitemid 8169802)
181. Jain MK and White HB 3rd. Long-range order in biomembranes. Adv Lipid Res 15: 1-60, 1977.
182. Jaiswal JK, Andrews NW, and Simon SM. Membrane proximal lysosomes are the major vesicles responsible for calcium-dependent exocytosis in nonsecretory cells. J Cell Biol 159: 625-635, 2002.
183. Jaksits S, Bauer W, Kriehuber E, Zeyda M, Stulnig TM, Stingl G, Fiebiger E, and Maurer D. Lipid raft-associated GTPase signaling controls morphology and CD8+ T cell stimulatory capacity of human dendritic cells. J Immunol 173: 1628-1639, 2004. (Pubitemid 38971593)
184. Jamaluddin M, Tian B, Boldogh I, Garofalo RP, and Brasier AR. Respiratory syncytial virus infection induces a reactive oxygen species-MSK1-phospho-Ser- 276 RelA pathway required for cytokine expression. J Virol 83: 10605-10615, 2009.
185. Jan JT, Chatterjee S, and Griffin DE. Sindbis virus entry into cells triggers apoptosis by activating sphingomyelinase, leading to the release of ceramide. J Virol 74: 6425-6432, 2000. (Pubitemid 30429809)
186. Jana A and Pahan K. Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J Biol Chem 279: 51451-51459, 2004. (Pubitemid 40017893)
187. Jardin I, Salido GM, and Rosado JA. Role of lipid rafts in the interaction between hTRPC1, Orai1 and STIM1. Channels (Austin) 2: 401-403, 2008.
188. Jia SJ, Jin S, Zhang F, Yi F, Dewey WL, and Li PL. Formation and function of ceramide-enriched membrane platforms with CD38 during M1-receptor stimulation in bovine coronary arterial myocytes. Am J Physiol Heart Circ Physiol 295: H1743-H1752, 2008.
189. Jin S, Yi F, and Li PL. Contribution of lysosomal vesicles to the formation of lipid raft redox signaling platforms in endothelial cells. Antioxid Redox Signal 9: 1417-1426, 2007. (Pubitemid 47255022)
190. Jin S, Yi F, Zhang F, Poklis JL, and Li PL. Lysosomal targeting and trafficking of acid sphingomyelinase to lipid raft platforms in coronary endothelial cells. Arterioscler Thromb Vasc Biol 28: 2056-2062, 2008.
191. Jin S, Zhang Y, Yi F, and Li PL. Critical role of lipid raft redox signaling platforms in endostatin-induced coronary endothelial dysfunction. Arterioscler Thromb Vasc Biol 28: 485-490, 2008.
192. Jin S and Zhou F. Lipid raft redox signaling platforms in vascular dysfunction: features and mechanisms. Curr Atheroscler Rep 11: 220-226, 2009.
193. Jin ZX, Huang CR, Dong L, Goda S, Kawanami T, Sawaki T, Sakai T, Tong XP, Masaki Y, Fukushima T, Tanaka M, Mimori T, Tojo H, Bloom ET, Okazaki T, and Umehara H. Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells. Int Immunol 20: 1427-1437, 2008.
194. Jose PA, Eisner GM, and Felder RA. Role of dopamine receptors in the kidney in the regulation of blood pressure. Curr Opin Nephrol Hypertens 11: 87-92, 2002. (Pubitemid 34053343)
195. Jung O, Schreiber JG, Geiger H, Pedrazzini T, Busse R, and Brandes RP. gp91phox-containing NADPH oxidase mediates endothelial dysfunction in renovascular hypertension. Circulation 109: 1795-1801, 2004. (Pubitemid 38500684)
196. Kaushal GP, Singh AB, and Shah SV. Identification of gene family of caspases in rat kidney and altered expression in ischemia-reperfusion injury. Am J Physiol 274: F587-F595, 1998.
197. Kawabe J, Okumura S, Nathanson MA, Hasebe N, and Ishikawa Y. Caveolin regulates microtubule polymerization in the vascular smooth muscle cells. Biochem Biophys Res Commun 342: 164-169, 2006. (Pubitemid 43250657)
198. Kenworthy AK, Petranova N, and Edidin M. Highresolution FRET microscopy of cholera toxin B-subunit and GPI-anchored proteins in cell plasma membranes. Mol Biol Cell 11: 1645-1655, 2000. (Pubitemid 30307902)
199. Khan N and Swartz H. Measurements in vivo of parameters pertinent to ROS/RNS using EPR spectroscopy. Mol Cell Biochem 234-235: 341-357, 2002. (Pubitemid 34784576)
200. Kietzmann T and Gorlach A. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol 16: 474-486, 2005.
201. Kim YJ, Nakatomi R, Akagi T, Hashikawa T, and Takahashi R. Unsaturated fatty acids induce cytotoxic aggregate formation of amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutants. J Biol Chem280: 21515-21521, 2005. (Pubitemid 40805717)
202. Kinnear NP, Boittin FX, Thomas JM, Galione A, and Evans AM. Lysosome-sarcoplasmic reticulum junctions. A trigger zone for calcium signaling by nicotinic acid adenine dinucleotide phosphate and endothelin-1. J Biol Chem 279: 54319-54326, 2004. (Pubitemid 40053170)
203. Kinoshita A, Fukumoto H, Shah T, Whelan CM, Irizarry MC, and Hyman BT. Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes. J Cell Sci 116: 3339-3346, 2003. (Pubitemid 37038982)
204. Kirkham M and Parton RG. Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim Biophys Acta 1746: 349-363, 2005.
205. Kirkham M and Parton RG. Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. Biochim Biophys Acta 1745: 273-286, 2005. (Pubitemid 41330782)
206. Kiss AL and Botos E. Endocytosis via caveolae: alternative pathway with distinct cellular compartments to avoid lysosomal degradation? J Cell Mol Med 13: 1228-1237, 2009.
207. Kitatani K, Idkowiak-Baldys J, and Hannun YA. The sphingolipid salvage pathway in ceramide metabolism and signaling. Cell Signal 20: 1010-1018, 2008.
208. Kojda G and Harrison D. Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure. Cardiovasc Res 43: 562-571, 1999. (Pubitemid 29369255)
209. Kolzer M, Arenz C, Ferlinz K, Werth N, Schulze H, Klingenstein R, and Sandhoff K. Phosphatidylinositol-3,5-Bisphosphate is a potent and selective inhibitor of acid sphingomyelinase. Biol Chem 384: 1293-1298, 2003. (Pubitemid 37168697)
210. Kondo N, Ishii Y, Kwon YW, Tanito M, Sakakura-Nishiyama J, Mochizuki M, Maeda M, Suzuki S, Kojima M, Kim YC, Son A, Nakamura H, and Yodoi J. Lipid raft-mediated uptake of cysteine-modified thioredoxin-1: apoptosis enhancement by inhibiting the endogenous thioredoxin-1. Antioxid Redox Signal 9: 1439-1448, 2007.
211. Kono H, Suzuki T, Yamamoto K, Okada M, Yamamoto T, and Honda Z. Spatial raft coalescence represents an initial step in Fc gamma R signaling. J Immunol 169: 193-203, 2002. (Pubitemid 34686136)
212. Korn ED. Structure and function of the plasma membrane. A biochemical perspective. J Gen Physiol 52: 257-278, 1968.
213. Kornhuber J, Reichel M, Tripal P, Groemer TW, Henkel AW, Muhle C, and Gulbins E. The role of ceramide in major depressive disorder. Eur Arch Psychiatry Clin Neurosci 259 Suppl 2: S199-S204, 2009.
214. Kornhuber J, Tripal P, Reichel M, Muhle C, Rhein C, Muehlbacher M, Groemer TW, and Gulbins E. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem 26: 9-20, 2010.
215. Kornhuber J, Tripal P, Reichel M, Terfloth L, Bleich S, Wiltfang J, and Gulbins E. Identification of new functional inhibitors of acid sphingomyelinase using a structureproperty-activity relation model. J Med Chem51: 219-237, 2008.
216. Kosugi A, Sakakura J, Yasuda K, Ogata M, and Hamaoka T. Involvement of SHP-1 tyrosine phosphatase in TCRmediated signaling pathways in lipid rafts. Immunity 14: 669-680, 2001. (Pubitemid 32592415)
217. Ksiazek K and Wisniewska J. [The role of glucose and reactive oxygen species in the development of vascular complications of diabetes mellitus]. Przegl Lek 58: 915-918, 2001.
218. Kulma M, Herec M, Grudzinski W, Anderluh G, Gruszecki WI, Kwiatkowska K, and Sobota A. Sphingomyelin-rich domains are sites of lysenin oligomerization: implications for raft studies. Biochim Biophys Acta 1798: 471-481, 2010.
219. Kusmartsev S and Gabrilovich DI. Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. J Leukoc Biol 74: 186-196, 2003. (Pubitemid 38040415)
220. Lambeth JD. Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. Curr Opin Hematol 9: 11-17, 2002. (Pubitemid 34025306)
221. Lang F, Gulbins E, Lang PA, Zappulla D, and Foller M. Ceramide in suicidal death of erythrocytes. Cell Physiol Biochem 26: 21-28, 2010.
222. Lang F, Lang KS, Lang PA, Huber SM, and Wieder T. Mechanisms and significance of eryptosis. Antioxid Redox Signal 8: 1183-1192, 2006. (Pubitemid 44182417)
223. Lassegue B and Clempus RE. Vascular NAD(P)H oxidases: specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-R297, 2003. (Pubitemid 36898897)
224. Laux T, Fukami K, Thelen M, Golub T, Frey D, and Caroni P. GAP43, MARCKS, and CAP23 modulate PI(4,5)P(2) at plasmalemmal rafts, and regulate cell cortex actin dynamics through a common mechanism. J Cell Biol 149: 1455-1472, 2000.
225. Lawrence DS, Zilfou JT, and Smith CD. Structure-activity studies of cerulenin analogues as protein palmitoylation inhibitors. J Med Chem 42: 4932-4941, 1999.
226. Lee HC. Nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated calcium signaling. J Biol Chem 280: 33693-33696, 2005. (Pubitemid 41443085)
227. Lefebvre B, Furt F, Hartmann MA, Michaelson LV, Carde JP, Sargueil-Boiron F, Rossignol M, Napier JA, Cullimore J, Bessoule JJ, and Mongrand S. Characterization of lipid rafts from Medicago truncatula root plasma membranes: a proteomic study reveals the presence of a raft-associated redox system. Plant Physiol 144: 402-418, 2007. (Pubitemid 46941606)
228. Legler DF, Micheau O, Doucey MA, Tschopp J, and Bron C. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity 18: 655-664, 2003. (Pubitemid 36588582)
229. Lenne PF, Wawrezinieck L, Conchonaud F, Wurtz O, Boned A, Guo XJ, Rigneault H, He HT, and Marguet D. Dynamic molecular confinement in the plasma membrane by microdomains and the cytoskeleton meshwork. EMBO J 25: 3245-3256, 2006. (Pubitemid 44141783)
230. Levitan I and Gooch KJ. Lipid rafts in membrane-cytoskeleton interactions and control of cellular biomechanics: actions of oxLDL. Antioxid Redox Signal 9: 1519-1534, 2007. (Pubitemid 47260439)
231. Levy M and Futerman AH. Mammalian ceramide synthases. IUBMB Life 62: 347-356, 2010.
232. Leyton L, Quest AF, and Bron C. Thy-1/CD3 coengagement promotes TCR signaling and enhances particularly tyrosine phosphorylation of the raft molecule LAT. Mol Immunol 36: 755-768, 1999. (Pubitemid 29526918)
233. Li H, Han W, Villar VA, Keever LB, Lu Q, Hopfer U, Quinn MT, Felder RA, Jose PA, and Yu P. D1-like receptors regulate NADPH oxidase activity and subunit expression in lipid raft microdomains of renal proximal tubule cells. Hypertension 53: 1054-1061, 2009.
234. Li PL and Gulbins E. Lipid rafts and redox signaling. Antioxid Redox Signal 9: 1411-1415, 2007. (Pubitemid 47255021)
235. Li PL, Zhang Y, and Yi F. Lipid raft redox signaling platforms in endothelial dysfunction. Antioxid Redox Signal 9: 1457-1470, 2007. (Pubitemid 47255026)
236. Li X, Becker KA, and Zhang Y. Ceramide in redox signaling and cardiovascular diseases. Cell Physiol Biochem 26: 41-48, 2010.
237. Lin CF, Chen CL, and Lin YS. Ceramide in apoptotic signaling and anticancer therapy. Curr Med Chem 13: 1609-1616, 2006. (Pubitemid 43821694)
238. Lin WC, Blanchette CD, Ratto TV, and Longo ML. Lipid domains in supported lipid bilayer for atomic force microscopy. Methods Mol Biol 400: 503-513, 2007. (Pubitemid 350183711)
239. Linder ME and Deschenes RJ. Palmitoylation: policing protein stability and traffic. Nat Rev Mol Cell Biol 8: 74-84, 2007. (Pubitemid 46012016)
240. Lingwood D, Kaiser HJ, Levental I, and Simons K. Lipid rafts as functional heterogeneity in cell membranes. Biochem Soc Trans 37: 955-960, 2009.
241. Lingwood D and Simons K. Lipid rafts as a membraneorganizing principle. Science 327: 46-50, 2010.
242. Liu CY, Lee CF, and Wei YH. Role of reactive oxygen species-elicited apoptosis in the pathophysiology of mitochondrial and neurodegenerative diseases associated with mitochondrial DNA mutations. J Formos Med Assoc 108: 599-611, 2009.
243. Lotocki G, Alonso OF, Dietrich WD, and Keane RW. Tumor necrosis factor receptor 1 and its signaling intermediates are recruited to lipid rafts in the traumatized brain. J Neurosci 24: 11010-11016, 2004. (Pubitemid 40012959)
244. Lu SP, Lin Feng MH, Huang HL, Huang YC, Tsou WI, and Lai MZ. Reactive oxygen species promote raft formation in T lymphocytes. Free Radic Biol Med 42: 936-944, 2007.
245. MacFarlane PM, Wilkerson JE, Lovett-Barr MR, and Mitchell GS. Reactive oxygen species and respiratory plasticity following intermittent hypoxia. Respir Physiol Neurobiol 164: 263-271, 2008.
246. Mackey AM, Sanvicens N, Groeger G, Doonan F, Wallace D, and Cotter TG. Redox survival signalling in retinaderived 661W cells. Cell Death Differ 15: 1291-1303, 2008. (Pubitemid 351984758)
247. Magee AI and Parmryd I. Detergent-resistant membranes and the protein composition of lipid rafts. Genome Biol 4: 234, 2003.
248. Mahammad S and Parmryd I. Cholesterol homeostasis in T cells. Methyl-beta-cyclodextrin treatment results in equal loss of cholesterol from Triton X-100 soluble and insoluble fractions. Biochim Biophys Acta 1778: 1251-1258, 2008.
249. Manes S, del Real G, and Martinez AC. Pathogens: raft hijackers. Nat Rev Immunol 3: 557-568, 2003. (Pubitemid 37328675)
250. Martinon F. Signaling by ROS drives inflammasome activation. Eur J Immunol 40: 616-619, 2010.
251. Martyn KD, Frederick LM, von Loehneysen K, Dinauer MC, and Knaus UG. Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases. Cell Signal 18: 69-82, 2006. (Pubitemid 41415716)
252. Mashimo M, Nishikawa M, Higuchi K, Hirose M, Wei Q, Haque A, Sasaki E, Shiba M, Tominaga K, Watanabe T, Fujiwara Y, Arakawa T, and Inoue M. Production of reactive oxygen species in peripheral blood is increased in individuals with Helicobacter pylori infection and decreased after its eradication. Helicobacter 11: 266-271, 2006. (Pubitemid 44051353)
253. Mas-Oliva J, and Delgado-Coello B. Protein stability and the evolution of the cell membrane. Comp Biochem Physiol C Toxicol Pharmacol 146: 207-213, 2007. (Pubitemid 47059056)
254. Mates JM and Sanchez-Jimenez FM. Role of reactive oxygen species in apoptosis: implications for cancer therapy. Int J Biochem Cell Biol 32: 157-170, 2000. (Pubitemid 30001819)
255. Mathias S and Kolesnick R. Ceramide: a novel second messenger. Adv Lipid Res 25: 65-90, 1993.
256. Mattjus P and Slotte JP. Does cholesterol discriminate between sphingomyelin and phosphatidylcholine in mixed monolayers containing both phospholipids? Chem Phys Lipids 81: 69-80, 1996. (Pubitemid 26257142)
257. McNeil PL and Kirchhausen T. An emergency response team for membrane repair. Nat Rev Mol Cell Biol 6: 499-505, 2005. (Pubitemid 40780561)
258. Mikuni S and Kinjo M. [Fluorescence correlation spectroscopy and fluorescence cross correlation spectroscopy for cell biology]. Tanpakushitsu Kakusan Koso 51: 1998-2005, 2006.
259. Mohazzab KM, Kaminski PM, and Wolin MS. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol 266: H2568-H2572, 1994. (Pubitemid 24215893)
260. Morgan MJ, Kim YS, and Liu Z. Lipid rafts and oxidative stress-induced cell death. Antioxid Redox Signal 9: 1471-1483, 2007. (Pubitemid 47255027)
261. Mukherjea D, Jajoo S, Kaur T, Sheehan KE, Ramkumar V, and Rybak LP. Transtympanic administration of short interfering (si)RNA for the NOX3 isoform of NADPH oxidase protects against cisplatin-induced hearing loss in the rat. Antioxid Redox Signal 13: 589-598, 2010.
262. Mukherjee SP, Lane RH, and Lynn WS. Endogenous hydrogen peroxide and peroxidative metabolism in adipocytes in response to insulin and sulfhydryl reagents. Biochem Pharmacol 27: 2589-2594, 1978. (Pubitemid 9072561)
263. Mukherjee SP, and Lynn WS. Reduced nicotinamide adenine dinucleotide phosphate oxidase in adipocyte plasma membrane and its activation by insulin. Possible role in the hormone's effects on adenylate cyclase and the hexose monophosphate shunt. Arch Biochem Biophys 184: 69-76, 1977. (Pubitemid 8220793)
264. Muller-Peddinghaus R. [Reactive oxygen species and inflammation]. Dtsch Tierarztl Wochenschr 96: 210-212, 1989.
265. Munday AD and Lopez JA. Posttranslational protein palmitoylation: promoting platelet purpose. Arterioscler Thromb Vasc Biol 27: 1496-1499, 2007. (Pubitemid 46986102)
266. Munro S. Lipid rafts: elusive or illusive? Cell 115: 377-388, 2003. (Pubitemid 37456801)
267. Murata T, Lin MI, Huang Y, Yu J, Bauer PM, Giordano FJ, and Sessa WC. Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J Exp Med 204: 2373-2382, 2007. (Pubitemid 47529323)
268. Murate T, Suzuki M, Hattori M, Takagi A, Kojima T, Tanizawa T, Asano H, Hotta T, Saito H, Yoshida S, and Tamiya-Koizumi K. Up-regulation of acid sphingomyelinase during retinoic acid-induced myeloid differentiation of NB4, a human acute promyelocytic leukemia cell line. J Biol Chem 277: 9936-9943, 2002. (Pubitemid 34968100)
269. Nabi IR and Le PU. Caveolae/raft-dependent endocytosis. J Cell Biol 161: 673-677, 2003. (Pubitemid 36648749)
270. Nada S, Hondo A, Kasai A, Koike M, Saito K, Uchiyama Y, and Okada M. The novel lipid raft adaptor p18 controls endosome dynamics by anchoring the MEK-ERK pathway to late endosomes. EMBO J 28: 477-489, 2009.
271. Nebl T, Pestonjamasp KN, Leszyk JD, Crowley JL, Oh SW, and Luna EJ. Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. J Biol Chem 277: 43399-43409, 2002. (Pubitemid 35285728)
272. Ng G, Chau EMT, and Shi Y. Recent developments in immune activation by uric acid crystals. Archivum Immunologiae Et Therapiae Experimentalis 58: 273-277, 2010.
273. Ng G, Sharma K, Ward SM, Desrosiers MD, Stephens LA, Schoel WM, Li T, Lowell CA, Ling CC, Amrein MW, and Shi Y. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 29: 807-818, 2008.
274. Ni X and Morales CR. The lysosomal trafficking of acid sphingomyelinase is mediated by sortilin and mannose 6-phosphate receptor. Traffic 7: 889-902, 2006. (Pubitemid 43871777)
275. Nicco C, Laurent A, Chereau C, Weill B, and Batteux F. Differential modulation of normal and tumor cell proliferation by reactive oxygen species. Biomed Pharmacother 59: 169-174, 2005. (Pubitemid 40603329)
276. Nichols BJ. A distinct class of endosome mediates clathrinindependent endocytosis to the Golgi complex. Nat Cell Biol 4: 374-378, 2002. (Pubitemid 34521033)
277. Nicolau DV Jr., Burrage K, Parton RG, and Hancock JF. Identifying optimal lipid raft characteristics required to promote nanoscale protein-protein interactions on the plasma membrane. Mol Cell Biol 26: 313-323, 2006.
278. Nieminen J, Kuno A, Hirabayashi J, and Sato S. Visualization of galectin-3 oligomerization on the surface of neutrophils and endothelial cells using fluorescence resonance energy transfer. J Biol Chem 282: 1374-1383, 2007. (Pubitemid 47076550)
279. Nika K, Charvet C, Williams S, Tautz L, Bruckner S, Rahmouni S, Bottini N, Schoenberger SP, Baier G, Altman A, and Mustelin T. Lipid raft targeting of hematopoietic protein tyrosine phosphatase by protein kinase C theta-mediated phosphorylation. Mol Cell Biol 26: 1806-1816, 2006.
280. Nini L, Waheed AA, Panicker LM, Czapiga M, Zhang JH, and Simonds WF. R7-binding protein targets the G protein beta 5/R7-regulator of G protein signaling complex to lipid rafts in neuronal cells and brain. BMC Biochem 8: 18, 2007.
281. Novgorodov SA and Gudz TI. Ceramide and mitochondria in ischemia/reperfusion. J Cardiovasc Pharmacol 53: 198-208, 2009.
282. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, and Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285, 1997. (Pubitemid 28015876)
283. Oakley FD, Abbott D, Li Q, and Engelhardt JF. Signaling components of redox active endosomes: the redoxosomes. Antioxid Redox Signal 11: 1313-1333, 2009.
284. Oakley FD, Smith RL, and Engelhardt JF. Lipid rafts and caveolin-1 coordinate interleukin-1beta (IL-1beta)-dependent activation of NFkappaB by controlling endocytosis of Nox2 and IL-1beta receptor 1 from the plasma membrane. J Biol Chem 284: 33255-33264, 2009.
285. Ochsendorf FR. Infection and reactive oxygen species. Andrologia 30 Suppl 1: 81-86, 1998. (Pubitemid 28244197)
286. Odani K, Kobayashi T, Ogawa Y, Yoshida S, and Seguchi H. ML-7 inhibits exocytosis of superoxide-producing intracellular compartments in human neutrophils stimulated with phorbol myristate acetate in a myosin light chain kinase-independent manner. Histochem Cell Biol 119: 363-370, 2003. (Pubitemid 36737051)
287. Oh KI, Kim BK, Ban YL, Choi EY, Jung KC, Lee IS, and Park SH. CD99 activates T cells via a costimulatory function that promotes raft association of TCR complex and tyrosine phosphorylation of TCR zeta. Exp Mol Med 39: 176-184, 2007.
288. Ong SL, Zhang Y, and Whitworth JA. Reactive oxygen species and glucocorticoid-induced hypertension. Clin Exp Pharmacol Physiol 35: 477-482, 2008. (Pubitemid 351326783)
289. Oshikawa J, Urao N, Kim HW, Kaplan N, Razvi M, McKinney R, Poole LB, Fukai T, and Ushio-Fukai M. Extracellular SOD-derived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-ischemic angiogenesis in mice. PLoS One 5: e10189, 2010.
290. Ostrom RS and Insel PA. The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol 143: 235-245, 2004. (Pubitemid 39315143)
291. Otahal P, Angelisova P, Hrdinka M, Brdicka T, Novak P, Drbal K, and Horejsi V. A new type of membrane raft-like microdomains and their possible involvement in TCR signaling. J Immunol 184: 3689-3696, 2010.
292. Oyagbemi AA, Azeez OI, and Saba AB. Interactions between reactive oxygen species and cancer: the roles of natural dietary antioxidants and their molecular mechanisms of action. Asian Pac J Cancer Prev 10: 535-544, 2009.
293. Pani B, Ong HL, Liu X, Rauser K, Ambudkar IS, and Singh BB. Lipid rafts determine clustering of STIM1 in endoplasmic reticulum-plasma membrane junctions and regulation of store-operated Ca2 + entry (SOCE). J Biol Chem 283: 17333-17340, 2008.
294. Paravicini TM and Touyz RM. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities. Diabetes Care 31 Suppl 2: S170-S180, 2008.
295. Park SJ, Kim HY, Kim H, Park SM, Joe EH, Jou I, and Choi YH. Oxidative stress induces lipid-raft-mediated activation of Src homology 2 domain-containing protein-tyrosine phosphatase 2 in astrocytes. Free Radic Biol Med 46: 1694-1702, 2009.
296. Parton RG and Richards AA. Lipid rafts and caveolae as portals for endocytosis: new insights and common mechanisms. Traffic 4: 724-738, 2003. (Pubitemid 37361854)
297. Patel RP, Moellering D, Murphy-Ullrich J, Jo H, Beckman JS, and Darley-Usmar VM. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radic Biol Med 28: 1780-1794, 2000. (Pubitemid 30628665)
298. Patra SK. Dissecting lipid raft facilitated cell signaling pathways in cancer. Biochim Biophys Acta 1785: 182-206, 2008.
299. Patterson SI. Posttranslational protein S-palmitoylation and the compartmentalization of signaling molecules in neurons. Biol Res 35: 139-150, 2002. (Pubitemid 35189787)
300. Pelkmans L. Secrets of caveolae-and lipid raft-mediated endocytosis revealed by mammalian viruses. Biochim Biophys Acta 1746: 295-304, 2005. (Pubitemid 41815023)
301. Pelkmans L, Burli T, Zerial M, and Helenius A. Caveolinstabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 118: 767-780, 2004. (Pubitemid 39221735)
302. Pelkmans L and Helenius A. Endocytosis via caveolae. Traffic 3: 311-320, 2002. (Pubitemid 34461041)
303. Pelkmans L, Kartenbeck J, and Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol 3: 473-483, 2001. (Pubitemid 32422083)
304. Perrone GG, Tan SX, and Dawes IW. Reactive oxygen species and yeast apoptosis. Biochim Biophys Acta 1783: 1354-1368, 2008.
305. Perry G, Castellani RJ, Hirai K, and Smith MA. Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease. J Alzheimers Dis 1: 45-55, 1998.
306. Peshavariya H, Dusting GJ, Di Bartolo B, Rye KA, Barter PJ, and Jiang F. Reconstituted high-density lipoprotein suppresses leukocyte NADPH oxidase activation by disrupting lipid rafts. Free Radic Res 43: 772-782, 2009.
307. Pi J, Zhang Q, Fu J, Woods CG, Hou Y, Corkey BE, Collins S, and Andersen ME. ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function. Toxicol Appl Pharmacol 244: 77-83, 2010.
308. Piccoli C, Ria R, Scrima R, Cela O, D'Aprile A, Boffoli D, Falzetti F, Tabilio A, and Capitanio N. Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel evidence of the occurrence of NAD(P)H oxidase activity. J Biol Chem 280: 26467-26476, 2005. (Pubitemid 41022243)
309. Pike LJ. Lipid rafts: heterogeneity on the high seas. Biochem J 378: 281-292, 2004. (Pubitemid 38367218)
310. Plowman SJ, Muncke C, Parton RG, and Hancock JF. H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton. Proc Natl Acad Sci USA 102: 15500-15505, 2005. (Pubitemid 41528086)
311. Plyte S, Majolini MB, Pacini S, Scarpini F, Bianchini C, Lanfrancone L, Pelicci P, and Baldari CT. Constitutive activation of the Ras/MAP kinase pathway and enhanced TCR signaling by targeting the Shc adaptor to membrane rafts. Oncogene 19: 1529-1537, 2000. (Pubitemid 30175674)
312. Pollard TD and Borisy GG. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112: 453-465, 2003. (Pubitemid 36263079)
313. Poteser M, Graziani A, Rosker C, Eder P, Derler I, Kahr H, Zhu MX, Romanin C, and Groschner K. TRPC3 and TRPC4 associate to form a redox-sensitive cation channel. Evidence for expression of native TRPC3-TRPC4 heteromeric channels in endothelial cells. J Biol Chem 281: 13588-13595, 2006. (Pubitemid 43855273)
314. Pralle A, Keller P, Florin EL, Simons K, and Horber JK. Sphingolipid-cholesterol rafts diffuse as small entities in the plasma membrane of mammalian cells. J Cell Biol 148: 997-1008, 2000.
315. Pritchard KA, Ackerman AW, Ou J, Curtis M, Smalley DM, Fontana JT, Stemerman MB, and Sessa WC. Native low-density lipoprotein induces endothelial nitric oxide synthase dysfunction: role of heat shock protein 90 and caveolin-1. Free Radic Biol Med 33: 52-62, 2002. (Pubitemid 34681006)
316. Puddu P, Puddu GM, Cravero E, Rosati M, and Muscari A. The molecular sources of reactive oxygen species in hypertension. Blood Press 17: 70-77, 2008. (Pubitemid 351891172)
317. Qin XS, Tsukaguchi H, Shono A, Yamamoto A, Kurihara H, and Doi T. Phosphorylation of nephrin triggers its internalization by raft-mediated endocytosis. J Am Soc Nephrol 20: 2534-2545, 2009.
318. Qiu H, Edmunds T, Baker-Malcolm J, Karey KP, Estes S, Schwarz C, Hughes H, Van and Patten SM. Activation of human acid sphingomyelinase through modification or deletion of C-terminal cysteine. J Biol Chem 278: 32744-32752, 2003. (Pubitemid 37055714)
319. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
320. Rao Malla R, Raghu H, and Rao JS. Regulation of NADPH oxidase (Nox2) by lipid rafts in breast carcinoma cells. Int J Oncol 37: 1483-1493, 2010.
321. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 19: 275-290, 2001. (Pubitemid 32368037)
322. Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Di Vizio D, Hou H Jr., Kneitz B, Lagaud G, Christ GJ, Edelmann W, and Lisanti MP. Caveolin-1 null mice are viable but show
323. Rehn M and Pihlajaniemi T. Alpha 1(XVIII), a collagen chain with frequent interruptions in the collagenous sequence, a distinct tissue distribution, and homology with type XV collagen. Proc Natl Acad Sci USA 91: 4234-4238, 1994.
324. Rentsch D, Boorer KJ, and Frommer WB. Structure and function of plasma membrane amino acid, oligopeptide and sucrose transporters from higher plants. J Membr Biol 162: 177-190, 1998. (Pubitemid 28206692)
325. Resh MD. Use of analogs and inhibitors to study the functional significance of protein palmitoylation. Methods 40: 191-197, 2006. (Pubitemid 44442977)
326. Rikihisa Y. Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum. Vet Parasitol 167: 155-166, 2010.
327. Rinia HA and de Kruijff B. Imaging domains in model membranes with atomic force microscopy. FEBS Lett 504: 194-199, 2001. (Pubitemid 32787069)
328. Rinia HA, Snel MM, van der Eerden JP, and de Kruijff B. Visualizing detergent resistant domains in model membranes with atomic force microscopy. FEBS Lett 501: 92-96, 2001. (Pubitemid 33712494)
329. Riteau B, Barber DF, and Long EO. Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization. J Exp Med 198: 469-474, 2003. (Pubitemid 36976057)
330. Rodighiero S, De Simoni A, and Formenti A. The voltagedependent nonselective cation current in human red blood cells studied by means of whole-cell and nystatinperforated patch-clamp techniques. Biochim Biophys Acta 1660: 164-170, 2004. (Pubitemid 38125243)
331. Rosen GM, Pou S, Ramos CL, Cohen MS, and Britigan BE. Free radicals and phagocytic cells. FASEB J 9: 200-209, 1995.
332. Rossin A, Kral R, Lounnas N, Chakrabandhu K, Mailfert S, Marguet D, and Hueber AO. Identification of a lysine-rich region of Fas as a raft nanodomain targeting signal necessary for Fas-mediated cell death. Exp Cell Res 316: 1513-1522, 2010.
333. Saitoh S, Zhang C, Tune JD, Potter B, Kiyooka T, Rogers PA, Knudson JD, Dick GM, Swafford A, and Chilian WM. Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. Arterioscler Thromb Vasc Biol 26: 2614-2621, 2006.
334. Salzer U, Hinterdorfer P, Hunger U, Borken C, and Prohaska R. Ca(+ +)-dependent vesicle release from erythrocytes involves stomatin-specific lipid rafts, synexin (annexin VII), and sorcin. Blood 99: 2569-2577, 2002. (Pubitemid 34525447)
335. Samhan-Arias AK, Garcia-Bereguiain MA, Martin-Romero FJ, and Gutierrez-Merino C. Clustering of plasma membrane-bound cytochrome b5 reductase within "lipid raft" microdomains of the neuronal plasma membrane. Mol Cell Neurosci 40: 14-26, 2009.
336. San Martin A and Griendling KK. Redox control of vascular smooth muscle migration. Antioxid Redox Signal 12: 625-640, 2010.
337. Sasaki H, Yamamoto H, Tominaga K, Masuda K, Kawai T, Teshima-Kondo S, and Rokutan K. NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts. J Med Invest 56: 33-41, 2009.
338. Sauer H, Wartenberg M, and Hescheler J. Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell Physiol Biochem 11: 173-186, 2001. (Pubitemid 32786086)
339. Say YH and Hooper NM. Contamination of nuclear fractions with plasma membrane lipid rafts. Proteomics 7: 1059-1064, 2007. (Pubitemid 46649155)
340. Scheel-Toellner D, Wang K, Assi LK, Webb PR, Craddock RM, Salmon M, and Lord JM. Clustering of death receptors in lipid rafts initiates neutrophil spontaneous apoptosis. Biochem Soc Trans 32: 679-681, 2004. (Pubitemid 39524351)
341. Schenck M, Carpinteiro A, Grassme H, Lang F, and Gulbins E. Ceramide: physiological and pathophysiological aspects. Arch Biochem Biophys 462: 171-175, 2007. (Pubitemid 46856326)
342. Schengrund CL. Lipid rafts: keys to neurodegeneration. Brain Res Bull 82: 7-17, 2010.
343. Schilling T and Eder C. Importance of lipid rafts for lysophosphatidylcholine-induced caspase-1 activation and reactive oxygen species generation. Cell Immunol 265: 87-90, 2010.
344. Schlegel A, Volonte D, Engelman JA, Galbiati F, Mehta P, Zhang XL, Scherer PE, and Lisanti MP. Crowded little caves: structure and function of caveolae. Cell Signal 10: 457-463, 1998. (Pubitemid 28404429)
345. Schmitz G and Grandl M. Role of redox regulation and lipid rafts in macrophages during Ox-LDL-mediated foam cell formation. Antioxid Redox Signal 9: 1499-1518, 2007. (Pubitemid 47255028)
346. Sengupta P, Baird B, and Holowka D. Lipid rafts, fluid/fluid phase separation, and their relevance to plasma membrane structure and function. Semin Cell Dev Biol 18: 583-590, 2007. (Pubitemid 350026424)
347. Shao D, Segal AW, and Dekker LV. Lipid rafts determine efficiency of NADPH oxidase activation in neutrophils. FEBS Lett 550: 101-106, 2003. (Pubitemid 37281365)
348. Sharma DK, Brown JC, Choudhury A, Peterson TE, Holicky E, Marks DL, Simari R, Parton RG, and Pagano RE. Selective stimulation of caveolar endocytosis by glycosphingolipids and cholesterol. Mol Biol Cell 15: 3114-3122, 2004. (Pubitemid 38850109)
349. Sheppard FR, Kelher MR, Moore EE, McLaughlin NJ, Banerjee A, and Silliman CC. Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J Leukoc Biol 78: 1025-1042, 2005. (Pubitemid 41572466)
350. Shiose A, Kuroda J, Tsuruya K, Hirai M, Hirakata H, Naito S, Hattori M, Sakaki Y, and Sumimoto H. A novel superoxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276: 1417-1423, 2001. (Pubitemid 32096573)
351. Siafakas AR, Wright LC, Sorrell TC, and Djordjevic JT. Lipid rafts in Cryptococcus neoformans concentrate the virulence determinants phospholipase B1 and Cu/Zn superoxide dismutase. Eukaryot Cell 5: 488-498, 2006.
352. Silva JP, Proenca F, and Coutinho OP. Protective role of new nitrogen compounds on ROS/RNS-mediated damage to PC12 cells. Free Radic Res 42: 57-69, 2008. (Pubitemid 351372192)
353. Silvius JR and Nabi IR. Fluorescence-quenching and resonance energy transfer studies of lipid microdomains in model and biological membranes. Mol Membr Biol 23: 5-16, 2006.
354. Simons K and Ehehalt R. Cholesterol, lipid rafts, and disease. J Clin Invest 110: 597-603, 2002. (Pubitemid 34988781)
355. Simons K and Gruenberg J. Jamming the endosomal system: lipid rafts and lysosomal storage diseases. Trends Cell Biol 10: 459-462, 2000.
356. Simons K and Ikonen E. Functional rafts in cell membranes. Nature 387: 569-572, 1997. (Pubitemid 27248754)
357. Simons K and Ikonen E. How cells handle cholesterol. Science 290: 1721-1726, 2000. (Pubitemid 32004797)
358. Simons K and Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1: 31-39, 2000.
359. Simons K and van Meer G. Lipid sorting in epithelial cells. Biochemistry 27: 6197-202, 1988.
360. Singer SJ. A fluid lipid-globular protein mosaic model of membrane structure. Ann N Y Acad Sci 195: 16-23, 1972.
361. Singer SJ and Nicolson GL. The fluid mosaic model of the structure of cell membranes. Science 175: 720-31, 1972.
362. Siow YL, Au-Yeung KK, Woo CW, and O K. Homocysteine stimulates phosphorylation of NADPH oxidase p47phox and p67phox subunits in monocytes via protein kinase Cbeta activation. Biochem J 398: 73-82, 2006.
363. Slaughter N, Laux I, Tu X, Whitelegge J, Zhu X, Effros R, Bickel P, and Nel A. The flotillins are integral membrane proteins in lipid rafts that contain TCR-associated signaling components: implications for T-cell activation. Clin Immunol 108: 138-151, 2003. (Pubitemid 36960076)
364. Smythies J. Redox aspects of signaling by catecholamines and their metabolites. Antioxid Redox Signal 2: 575-583, 2000.
365. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, and Lisanti MP. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 271: 9690-9697, 1996.
366. Sorice M, Manganelli V, Matarrese P, Tinari A, Misasi R, Malorni W, and Garofalo T. Cardiolipin-enriched raft-like microdomains are essential activating platforms for apoptotic signals on mitochondria. FEBS Lett 583: 2447-2450, 2009.
367. Soubias O and Gawrisch K. Nuclear magnetic resonance investigation of oriented lipid membranes. Methods Mol Biol 400: 77-88, 2007. (Pubitemid 350183683)
368. Sowa G, Pypaert M, and Sessa WC. Distinction between signaling mechanisms in lipid rafts vs. caveolae. Proc Natl Acad Sci USA 98: 14072-14077, 2001. (Pubitemid 33116026)
369. Stadtman ER. Role of oxidant species in aging. Curr Med Chem 11: 1105-12, 2004. (Pubitemid 38585056)
370. Stan RV. Structure and function of endothelial caveolae. Microsc Res Tech 57: 350-364, 2002.
371. Stancevic B and Kolesnick R. Ceramide-rich platforms in transmembrane signaling. FEBS Lett 584: 1728-1740, 2010.
372. Steinbauer B, Mehnert T, and Beyer K. Hydration and lateral organization in phospholipid bilayers containing sphingomyelin: a 2H-NMR study. Biophys J 85: 1013-1024, 2003. (Pubitemid 36909665)
373. Stuven E, Porat A, Shimron F, Fass E, Kaloyanova D, Brugger B, Wieland FT, Elazar Z, and Helms JB. Intra-Golgi protein transport depends on a cholesterol balance in the lipid membrane. J Biol Chem 278: 53112-53122, 2003. (Pubitemid 38035915)
374. Sumimoto H, Miyano K, and Takeya R. Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun 338: 677-686, 2005. (Pubitemid 41540615)
375. Sun G, Xu X, Wang Y, Shen X, Chen Z, and Yang J. Mycoplasma pneumoniae infection induces reactive oxygen species and DNA damage in A549 human lung carcinoma cells. Infect Immun 76: 4405-4413, 2008.
376. Suzuki KG, Fujiwara TK, Sanematsu F, Iino R, Edidin M, and Kusumi A. GPI-anchored receptor clusters transiently recruit Lyn and G alpha for temporary cluster immobilization and Lyn activation: single-molecule tracking study J Cell Biol 177: 717-730, 2007. (Pubitemid 46799842)
377. Sverdlov M, Shajahan AN, and Minshall RD. Tyrosine phosphorylation- dependence of caveolae-mediated endocytosis. J Cell Mol Med 11: 1239-1250, 2007.
378. Szanto I, Rubbia-Brandt L, Kiss P, Steger K, Banfi B, Kovari E, Herrmann F, Hadengue A, and Krause KH. Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol 207: 164-176, 2005. (Pubitemid 41404147)
379. Szocs K. Endothelial dysfunction and reactive oxygen species production in ischemia/reperfusion and nitrate tolerance. Gen Physiol Biophys 23: 265-295, 2004. (Pubitemid 39485250)
380. Szoke E, Borzsei R, Toth DM, Lengl O, Helyes Z, Sandor Z, and Szolcsanyi J. Effect of lipid raft disruption on TRPV1 receptor activation of trigeminal sensory neurons and transfected cell line. Eur J Pharmacol 628: 67-74, 2010.
381. Tang XL, Takano H, Rizvi A, Turrens JF, Qiu Y, Wu WJ, Zhang Q, and Bolli R. Oxidant species trigger late preconditioning against myocardial stunning in conscious rabbits. Am J Physiol Heart Circ Physiol 282: H281-H291, 2002. (Pubitemid 34654160)
382. Tani M, Ito M, and Igarashi Y. Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Cell Signal 19: 229-237, 2007. (Pubitemid 44969975)
383. Tian W, Li XJ, Stull ND, Ming W, Suh CI, Bissonnette SA, Yaffe MB, Grinstein S, Atkinson SJ, and Dinauer MC. Fc{gamma}R-stimulated activation of the NADPH oxidase: phosphoinositide-binding protein p40phox regulates NADPH oxidase activity after enzyme assembly on the phagosome. Blood 112: 3867-3877, 2008.
384. Toledo-Pereyra LH, Lopez-Neblina F, and Toledo AH. Reactive oxygen species and molecular biology of ischemia/reperfusion. Ann Transplant 9: 81-83, 2004.
385. Touyz RM. Lipid rafts take center stage in endothelial cell redox signaling by death receptors. Hypertension 47: 16-18, 2006. (Pubitemid 43177808)
386. Ueda N, Kaushal GP, and Shah SV. Apoptotic mechanisms in acute renal failure. Am J Med 108: 403-415, 2000. (Pubitemid 30162959)
387. Ueno N, Takeya R, Miyano K, Kikuchi H, and Sumimoto H. The NADPH oxidase Nox3 constitutively produces superoxide in a p22phox-dependent manner: its regulation by oxidase organizers and activators. J Biol Chem 280: 23328-23339, 2005. (Pubitemid 40853246)
388. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci STKE 2006: re8, 2006.
389. Ushio-Fukai M. Compartmentalization of redox signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 11: 1289-1299, 2009.
390. Ushio-Fukai M and Alexander RW. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol Cell Biochem 264: 85-97, 2004. (Pubitemid 39366107)
391. Ushio-Fukai M, Hilenski L, Santanam N, Becker PL, Ma Y, Griendling KK, and Alexander RW. Cholesterol depletion inhibits epidermal growth factor receptor transactivation by angiotensin II in vascular smooth muscle cells: role of cholesterol-rich microdomains and focal adhesions in angiotensin II signaling. J Biol Chem 276: 48269-48275, 2001.
392. Utermohlen O, Herz J, Schramm M, and Kronke M. Fusogenicity of membranes: the impact of acid sphingomyelinase on innate immune responses. Immunobiology 213: 307-314, 2008.
393. Valensin S, Paccani SR, Ulivieri C, Mercati D, Pacini S, Patrussi L, Hirst T, Lupetti P, and Baldari CT. F-actin dynamics control segregation of the TCR signaling cascade to clustered lipid rafts. Eur J Immunol 32: 435-446, 2002. (Pubitemid 34173335)
394. van Meer G and Simons K. Lipid polarity and sorting in epithelial cells. J Cell Biochem 36: 51-58, 1988.
395. Van Wart HE and Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87: 5578-5582, 1990.
396. van Zanten TS, Cambi A, Koopman M, Joosten B, Figdor CG, and Garcia-Parajo MF. Hotspots of GPI-anchored proteins and integrin nanoclusters function as nucleation sites for cell adhesion. Proc Natl Acad Sci USA 106: 18557-18562, 2009.
397. Vetrivel KS, Cheng H, Lin W, Sakurai T, Li T, Nukina N, Wong PC, Xu H, and Thinakaran G. Association of gammasecretase with lipid rafts in post-Golgi and endosome membranes. J Biol Chem 279: 44945-44954, 2004. (Pubitemid 39430908)
398. Vilhardt F and van Deurs B. The phagocyte NADPH oxidase depends on cholesterol-enriched membrane microdomains for assembly. EMBO J 23: 739-748, 2004. (Pubitemid 38418741)
399. Wan J, Roth AF, Bailey AO, and Davis NG. Palmitoylated proteins: purification and identification. Nat Protoc 2: 1573-1584, 2007. (Pubitemid 47033750)
400. Wang HD, Johns DG, Xu S, and Cohen RA. Role of superoxide anion in regulating pressor and vascular hypertrophic response to angiotensin II. Am J Physiol Heart Circ Physiol 282: H1697-702, 2002. (Pubitemid 34654837)
401. Wang L, Sapuri-Butti AR, Aung HH, Parikh AN, and Rutledge JC. Triglyceride-rich lipoprotein lipolysis increases aggregation of endothelial cell membrane microdomains and produces reactive oxygen species. Am J Physiol Heart Circ Physiol 295: H237-H244, 2008.
402. Wang T, Gu J, Wu PF, Wang F, Xiong Z, Yang YJ, Wu WN, Dong LD, and Chen JG. Protection by tetrahydroxystilbene glucoside against cerebral ischemia: involvement of JNK, SIRT1, and NF-kappaB pathways and inhibition of intracellular ROS/RNS generation. Free Radic Biol Med 47: 229-240, 2009.
403. Wang X, Tian QB, Okano A, Sakagami H, Moon IS, Kondo H, Endo S, and Suzuki T. BAALC 1-6-8 protein is targeted to postsynaptic lipid rafts by its N-terminal myristoylation and palmitoylation, and interacts with alpha, but not beta, subunit of Ca/calmodulin-dependent protein kinase II. J Neurochem 92: 647-659, 2005. (Pubitemid 40189467)
404. Wang YX and Zheng YM. ROS-dependent signaling mechanisms for hypoxic Ca(2 + ) responses in pulmonary artery myocytes. Antioxid Redox Signal 12: 611-623, 2010.
405. Watanabe M, Wake H, Moorhouse AJ, and Nabekura J. Clustering of neuronal K+-Cl-cotransporters in lipid rafts by tyrosine phosphorylation. J Biol Chem 284: 27980-27988, 2009.
406. Waugh MG, Minogue S, Anderson JS, dos Santos M, and Hsuan JJ. Signalling and non-caveolar rafts. Biochem Soc Trans 29: 509-511, 2001.
407. Weaver AK, Olsen ML, McFerrin MB, and Sontheimer H. BK channels are linked to inositol 1,4,5-triphosphate receptors via lipid rafts: a novel mechanism for coupling [Ca(2 + )](i) to ion channel activation. J Biol Chem 282: 31558-31568, 2007. (Pubitemid 350044881)
408. Wei XF, Zhou QG, Hou FF, Liu BY, and Liang M. Advanced oxidation protein products induce mesangial cell perturbation through PKC-dependent activation of NADPH oxidase. Am J Physiol Renal Physiol 296: F427-F437, 2009.
409. Weinberg F and Chandel NS. Reactive oxygen speciesdependent signaling regulates cancer. Cell Mol Life Sci 66: 3663-3673, 2009.
410. Weintraub NL. Nox response to injury. Arterioscler Thromb Vasc Biol 22: 4-5, 2002. (Pubitemid 34076224)
411. Whaley-Connell A, Habibi J, Nistala R, Cooper SA, Karuparthi PR, Hayden MR, Rehmer N, DeMarco VG, Andresen BT, Wei Y, Ferrario C, and Sowers JR. Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment. Hypertension 51: 474-480, 2008. (Pubitemid 351156435)
412. White BH and Sidhu A. Increased oxidative stress in renal proximal tubules of the spontaneously hypertensive rat: a mechanism for defective dopamine D1A receptor/G-protein coupling. J Hypertens 16: 1659-1665, 1998. (Pubitemid 28515493)
413. Wolf G. Role of reactive oxygen species in angiotensin IImediated renal growth, differentiation, and apoptosis. Antioxid Redox Signal 7: 1337-1345, 2005. (Pubitemid 41232531)
414. Wolin MS. Subcellular localization of Nox-containing oxidases provides unique insight into their role in vascular oxidant signaling. Arterioscler Thromb Vasc Biol 24: 625-627, 2004. (Pubitemid 38451595)
415. Wolin MS, Ahmad M, Gao Q, and Gupte SA. Cytosolic NAD(P)H regulation of redox signaling and vascular oxygen sensing. Antioxid Redox Signal 9: 671-678, 2007. (Pubitemid 46799099)
416. Wolin MS, Ahmad M, and Gupte SA. Oxidant and redox signaling in vascular oxygen sensing mechanisms: basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol 289: L159-L173, 2005. (Pubitemid 41008897)
417. Wolin MS, Ahmad M, and Gupte SA. The sources of oxidative stress in the vessel wall. Kidney Int 67: 1659-1661, 2005. (Pubitemid 40577694)
418. Woudenberg J, Rembacz KP, van den Heuvel FA, Woudenberg-Vrenken TE, Buist-Homan M, Geuken M, Hoekstra M, Deelman LE, Enrich C, Henning RH, Moshage H, and Faber KN. Caveolin-1 is enriched in the peroxisomal membrane of rat hepatocytes. Hepatology 51: 1744-1753, 2010.
419. Wu H, Mahmood A, Lu D, Jiang H, Xiong Y, Zhou D, and Chopp M. Attenuation of astrogliosis and modulation of endothelial growth factor receptor in lipid rafts by simvastatin after traumatic brain injury. J Neurosurg 113: 591-597, 2010.
420. Xia F, Gao X, Kwan E, Lam PP, Chan L, Sy K, Sheu L, Wheeler MB, Gaisano HY, and Tsushima RG. Disruption of pancreatic beta-cell lipid rafts modifies Kv2.1 channel gating and insulin exocytosis. J Biol Chem 279: 24685-24691, 2004. (Pubitemid 38725336)
421. Yamamoto S, Shimizu S, and Mori Y. Involvement of TRPM2 channel in amplification of reactive oxygen speciesinduced signaling and chronic inflammation. Nippon Yakurigaku Zasshi 134: 122-126, 2009.
422. Yang B, Oo TN, and Rizzo V. Lipid rafts mediate H2O2 prosurvival effects in cultured endothelial cells. Faseb J 20: 1501-1503, 2006.
423. Yang B and Rizzo V. TNF-alpha potentiates proteintyrosine nitration through activation of NADPH oxidase and eNOS localized in membrane rafts and caveolae of bovine aortic endothelial cells. Am J Physiol Heart Circ Physiol 292: H954-H962, 2007.
424. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, Wang X, Quinn MT, Sibley DR, Romero GG, Felder RA, and Jose PA. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol 290: R96-R104, 2006.
425. Yao Y, Hong S, Zhou H, Yuan T, Zeng R, and Liao K. The differential protein and lipid compositions of noncaveolar lipid microdomains and caveolae. Cell Res 19: 497-506, 2009.
426. Yaqoob P. The nutritional significance of lipid rafts. Annu Rev Nutr 29: 257-282, 2009.
427. Yasunari K, Kohno M, Kano H, Minami M, and Yoshikawa J. Dopamine as a novel antioxidative agent for rat vascular smooth muscle cells through dopamine D(1)-like receptors. Circulation 101: 2302-2308, 2000. (Pubitemid 30317134)
428. Yi F, Chen QZ, Jin S, and Li PL. Mechanism of homocysteine-induced Rac1/NADPH oxidase activation in mesangial cells: role of guanine nucleotide exchange factor Vav2. Cell Physiol Biochem 20: 909-918, 2007. (Pubitemid 350059734)
429. Yi F, Jin S, and Li PL. Lipid raft-redox signaling platforms in plasma membrane. Methods Mol Biol 580: 93-107, 2009.
430. Yi F, Jin S, Zhang F, Xia M, Bao JX, Hu J, Poklis JL, and Li PL. Formation of lipid raft redox signalling platforms in glomerular endothelial cells: an early event of homocysteine-induced glomerular injury. J Cell Mol Med 13: 3303-3314, 2009.
431. Yi F, Xia M, Li N, Zhang C, Tang L, and Li PL. Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats. Hypertension 53: 90-96, 2009.
432. Yi F, Zhang AY, Janscha JL, Li PL, and Zou AP. Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. Kidney Int 66: 1977-1987, 2004.
433. Yi XY, Li VX, Zhang F, Yi F, Matson DR, Jiang MT, and Li PL. Characteristics and actions of NAD(P)H oxidase on the sarcoplasmic reticulum of coronary artery smooth muscle. Am J Physiol Heart Circ Physiol 290: H1136-H1144, 2006.
434. Yin T, Sandhu G, Wolfgang CD, Burrier A, Webb RL, Rigel DF, Hai T, and Whelan J. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem 272: 19943-19950, 1997. (Pubitemid 27340095)
435. Ying M, Grimmer S, Iversen TG, Van Deurs B, and Sandvig K. Cholesterol loading induces a block in the exit of VSVG from the TGN. Traffic 4: 772-784, 2003. (Pubitemid 37361857)
436. Young RM, Zheng X, Holowka D, and Baird B. Reconstitution of regulated phosphorylation of FcepsilonRI by a lipid raft-excluded protein-tyrosine phosphatase. J Biol Chem 280: 1230-1235, 2005.
437. Yu P, Yang Z, Jones JE, Wang Z, Owens SA, Mueller SC, Felder RA, and Jose PA. D1 dopamine receptor signaling involves caveolin-2 in HEK-293 cells. Kidney Int 66: 2167-2180, 2004. (Pubitemid 41115280)
438. Yuan T, Hong S, Yao Y, and Liao K. Glut-4 is translocated to both caveolae and non-caveolar lipid rafts, but is partially internalized through caveolae in insulin-stimulated adipocytes. Cell Res 17: 772-782, 2007. (Pubitemid 47409702)
439. Zabrocki P, Bastiaens I, Delay C, Bammens T, Ghillebert R, Pellens K, De Virgilio C, Van Leuven F, and Winderickx J. Phosphorylation, lipid raft interaction and traffic of alphasynuclein in a yeast model for Parkinson. Biochim Biophys Acta 1783: 1767-1780, 2008.
440. Zeng C, Villar VA, Yu P, Zhou L, and Jose PA. Reactive oxygen species and dopamine receptor function in essential hypertension. Clin Exp Hypertens 31: 156-178, 2009.
441. Zhai J, Strom AL, Kilty R, Venkatakrishnan P, White J, Everson WV, Smart EJ, and Zhu H. Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord. FEBS J 276: 3308-3323, 2009.
442. Zhang AY, Teggatz EG, Zou AP, Campbell WB, and Li PL. Endostatin uncouples NO and Ca2 + response to bradykinin through enhanced O2*-production in the intact coronary endothelium. Am J Physiol Heart Circ Physiol 288: H686-H694, 2005. (Pubitemid 40139651)
443. Zhang AY, Yi F, Jin S, Xia M, Chen QZ, Gulbins E, and Li PL. Acid sphingomyelinase and its redox amplification in formation of lipid raft redox signaling platforms in endothelial cells. Antioxid Redox Signal 9: 817-828, 2007.
444. Zhang AY, Yi F, Zhang G, Gulbins E, and Li PL. Lipid raft clustering and redox signaling platform formation in coronary arterial endothelial cells. Hypertension 47: 74-80, 2006. (Pubitemid 43177818)
445. Zhang C, Hu JJ, Xia M, Boini KM, Brimson C, and Li PL. Redox signaling via lipid raft clustering in homocysteineinduced injury of podocytes. Biochim Biophys Acta 1803: 482-491, 2010.
446. Zhang C and Li PL. Membrane raft redox signalosomes in endothelial cells. Free Radic Res 44: 831-842, 2010.
447. Zhang F, Zhang G, Zhang AY, Koeberl MJ, Wallander E, and Li PL. Production of NAADP and its role in Ca2 + mobilization associated with lysosomes in coronary arterial myocytes. Am J Physiol Heart Circ Physiol 291: H274-H282, 2006.
448. Zhang G, Zhang F, Muh R, Yi F, Chalupsky K, Cai H, and Li PL. Autocrine/paracrine pattern of superoxide production through NAD(P)H oxidase in coronary arterial myocytes. Am J Physiol Heart Circ Physiol 292: H483-H495, 2007. (Pubitemid 46105211)
449. Zhang Y, Li X, Becker KA, and Gulbins E. Ceramide-enriched membrane domains-structure and function. Biochim Biophys Acta 1788: 178-183, 2009.
450. Zheng L, McQuaw CM, Ewing AG, and Winograd N. Sphingomyelin/ phosphatidylcholine and cholesterol interactions studied by imaging mass spectrometry. J Am Chem Soc 129: 15730-15731, 2007.
451. Zheng YZ, Berg KB, and Foster LJ. Mitochondria do not contain lipid rafts, and lipid rafts do not contain mitochondrial proteins. J Lipid Res 50: 988-998, 2009.
452. Zuo L, Ushio-Fukai M, Hilenski LL, and Alexander RW. Microtubules regulate angiotensin II type 1 receptor and Rac1 localization in caveolae/lipid rafts: role in redox signaling. Arterioscler Thromb Vasc Biol 24: 1223-1228, 2004. (Pubitemid 38880012)
453. Zuo L, Ushio-Fukai M, Ikeda S, Hilenski L, Patrushev N, and Alexander RW. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy. Arterioscler Thromb Vasc Biol 25: 1824-1830, 2005. (Pubitemid 41243449)
454. Zurzolo C, van't Hof W, van Meer G, and Rodriguez-Boulan E. VIP21/caveolin, glycosphingolipid clusters and the sorting of glycosylphosphatidylinositol-anchored proteins in epithelial cells. EMBO J 13: 42-53, 1994.